# Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction

> **NCT02943356** · PHASE4 · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 40 (estimated)

## Conditions studied

- Erectile Dysfunction
- Andropause

## Interventions

- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT02943356
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02943356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02943356, "Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02943356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*